Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Cypress Bioscience and Fresenius sign definitive agreement for Prosorba Column

March 11, 1999

Merck Frosst presents clinical data on COX-2 inhibitor at Canadian meeting

March 10, 1999

Microbial metabolite inhibits ICAM-1/LFA-1-mediated cell adhesion

March 8, 1999

Cyclooxygenase-inhibitory indoles under study at Pfizer

March 8, 1999

Cytokine production inhibitors prepared and tested at Ortho-McNeil

March 4, 1999

Medarex joins forces with Danish investors to develop human antibody therapeutics

March 4, 1999

Cysteine protease-inhibitory peptides disclosed by Takeda

March 2, 1999

New MMP and/or TNF production inhibitors developed by Pfizer research group

March 2, 1999

Clinical study of La Jolla's lupus drug expanded to Europe and Canada

March 2, 1999

Zimmer launches Orthovisc in Europe; prepares to begin North American trials

Feb. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...